Wellness products maker Aixin Life (AIXN), which is seeking to uplist its shares to Nasdaq, has downsized its proposed public offering by 50% to $25M. Read more here.
BioNexus Gene Lab (BGLC), a wholesaler of chemical raw materials and developer of liquid biopsy tests, has filed to uplist its shares to Nasdaq. Read more here.
China-focused wellness products marketer Aixin Life International (AIXN) plans to uplist its shares to Nasdaq and conduct a $50M public offering. Read more on the deal here.
Following some spotty IPOs recently, Starbox Group Holdings Ltd. delivers a profitable fintech ecosystem that may play into the broader digitalization movement.